The certification covers how non-clinical health and environmental safety studies are planned, run, and reported.
Name: Ralph Oehlmann
This article has been updated from a previous version to include updated specs from PacBio on the average read length for its sequencer.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.